In a recent study, researchers from the Medical University of South Carolina divided 37 men with low-grade prostate tumors waiting for prostatectomies into two groups.
Group 1 was given a vitamin D supplement and group 2 was given a placebo. What they found was that the vitamin D group showed a major reduction in the lipids and proteins involved in the inflammation of the prostate gland, which led to better patient outcomes.
Previous studies also demonstrated that vitamin D supplementation for at least a year improved Gleason scores (used to grade the aggressiveness of tumors), and in some cases completely eradicated the tumor.
For pharmaceutical grade vitamin D3, we recommend Thorne Research.
- 10,000 iu
- 25,000 iu